Dp Derm | Microneedling Device Company of the Year 2026

MedTech Outlook Magazine

Dp Derm
Turning Microneedling into More Consistent Results

Joel Marshall, Dp Derm | Medical Tech Outlook | Microneedling Device Company of the YearJoel Marshall, CEO
What factors influence the consistency of outcomes in microneedling treatments across clinics?

In microneedling, stronger results depend on more than the device alone. They are shaped by how the skin is prepared, how the procedure is performed and how recovery is supported afterward. Across concerns such as acne, uneven texture, pigmentation and age-related skin changes, outcomes are often stronger when those stages are managed as one connected pathway.

In many clinics, devices, products and protocols still operate separately, making consistent outcomes harder to achieve.

Dp Derm addresses that gap by structuring microneedling as a protocol-led treatment model designed to improve consistency from preparation through recovery and help clinics deliver more confident, results-driven care.

At the center is Dermapen 4, supported by the Dp Dermaceuticals range for preparation, in-procedure use and post-treatment care. Practitioner education, indication-specific protocols, provider resources and home care products help clinics manage treatment more consistently while giving clients a more complete experience from start to finish.

“It’s about providing a bespoke approach to microneedling. A Dermapen treatment is designed as an elevated treatment, not just a standard microneedling procedure,” says Joel Marshall, CEO.

Improving Precision and Treatment Experience

How does device precision contribute to improved treatment delivery and patient experience?

Dermapen 4 is designed to support more controlled delivery. Its features include digital depth control, faster treatment speed and the ability to create more than a million micro-channels in under 10 minutes. These capabilities can also reduce reliance on anesthetics, allowing treatment to be performed with greater control and efficiency. FDA-cleared for the treatment of facial acne scars and equipped with a dedicated Scar Treatment setting, it supports a more precise procedural approach.

That precision becomes more valuable when it is paired with a coordinated treatment plan. Dp Derm aligns skin preparation, in-procedure support and post-treatment care with the indication being treated, giving practitioners a clearer treatment pathway and helping clients move through the process with greater continuity.

In acne treatment, for example, improvement can be seen with clearer skin contributing to greater confidence. More broadly, this reflects how aligning preparation, treatment and follow-up can help clinics deliver microneedling with more consistent and meaningful results.
Supporting Better Clinic Execution

Why is practitioner education essential for maintaining consistent microneedling outcomes in clinics?

Because outcomes depend on consistent execution, education is built into the offering. Dp Derm supports providers through online training, onboarding, in-clinic sessions, multi-day training programs and Continuing Medical Education courses.

“We equip practitioners with the tools to deliver the best possible results for their clients,” says Marshall.

  • It’s really about providing a bespoke approach to microneedling. A Dermapen treatment is designed as an elevated treatment, not just a standard microneedling procedure.


That support also strengthens day-to-day clinic execution. A treatment may be clinically strong, but it can still fall short if it is not explained clearly, integrated properly or delivered consistently across the team. Dp Derm helps providers present the treatment and related products in a way that is easier to embed in practice, creating a clearer framework for staff and a more structured experience for clients.

The business impact follows from that structure. Lower per-treatment supply costs can improve profitability by reducing the cost attached to each session. Consistent delivery and a stronger treatment offering can also help clinics retain clients, encourage repeat visits and embed microneedling more firmly within the practice. In this way, Dp Derm connects treatment quality, practitioner readiness and business performance within the same operating model.

Extending the Offering Across Indications

In what way does expanding treatment applications enhance the overall value of microneedling?

Hair restoration shows how Dp Derm extends this approach into another high-impact area. The process begins with scalp assessment, supported by follicle scanning, before moving into in-clinic microneedling paired with hair-focused exosomes.

It then continues through home support with a daily tonic, shampoo, conditioner and pre-shower mask. A tablet, supplement, and LED and laser cap add further support, creating a regimen designed to sustain progress over time.

Expanding Results Through Regeneration

Dp Derm extends its regenerative offering to both skin and hair applications. Emphasizing amniotic-fluid-derived formulations with HLA-G protein, the company positions exosomes as a way to support repair over repeated sessions and strengthen response over time. Patented technologies associated with this part of the portfolio further underline the importance of exosomes within its broader regenerative direction.

The same focus on stronger results shapes the company’s broader interest in biologics. As regenerative science advances, greater emphasis is expected to fall on combining external treatment support with internal support, including supplements. In that direction, microneedling remains the procedural foundation, while biologics and related adjuncts widen the potential of what treatment can achieve.

AI also sits within that longer-term outlook. Its significance lies in the ability to gather information, connect ideas and accelerate innovation across biologics and regenerative technology. In the near term, the more immediate value lies in the treatment architecture Dp Derm is already building around microneedling.

Dp Derm’s recognition as the Microneedling Device Company of the Year 2026 reflects the strength of that proposition. As the offering evolves, Dp Derm is advancing a treatment model designed to make results more repeatable across practices, broaden clinical application and create stronger long-term value for both clinics and their clients.

Deep Dive

Advancing Precision and Outcomes in Professional Microneedling

The rapid growth of minimally invasive aesthetic treatments has elevated expectations around consistency, safety and measurable skin outcomes. Executives evaluating microneedling solutions are no longer choosing between devices alone; they are assessing how effectively a solution enables practitioners to deliver repeatable, high-quality results......Read more

Microneedling Device Info

Q1

Why is Dp Derm recognized in the microneedling technology market?

Dp Derm has established a strong presence in the Microneedling Devices sector through its focus on advanced skin treatment technology designed for professional aesthetic applications. The company develops microneedling systems that support controlled skin rejuvenation procedures while emphasizing precision, consistency and treatment efficiency. Its product approach combines device engineering with practitioner usability, helping aesthetic professionals perform procedures with greater confidence and control. By concentrating on clinically oriented Microneedling Devices, Dp Derm continues to strengthen its position within the evolving aesthetics and skincare technology market.

Q2

What differentiates Dp Derm from other microneedling device providers?

Precision-focused engineering and treatment consistency distinguish Dp Derm within the Microneedling Devices category. The company develops devices designed to support adjustable treatment settings, controlled needle depth and efficient procedural workflows for aesthetic professionals. Its emphasis on professional-grade performance and device reliability helps support a more predictable treatment experience. Dp Derm also prioritizes product quality and usability, allowing its Microneedling Devices to align with the needs of clinics and practitioners seeking dependable skin treatment technology.

Q3

How does Dp Derm support aesthetic professionals?

Dp Derm supports aesthetic practitioners through product education, treatment guidance and technical resources associated with its Microneedling Devices. The company focuses on helping professionals understand device functionality, treatment applications and procedural best practices to improve treatment consistency and operational efficiency. Clear product support and practitioner-focused resources contribute to a smoother integration of microneedling technology into aesthetic service environments. This support-oriented approach helps professionals maximize the value and performance of Dp Derm’s treatment systems.

Q4

How do Dp Derm’s devices create value for aesthetic practices?

Reliable performance and procedural efficiency contribute significantly to the value of Dp Derm’s Microneedling Devices. The company’s systems are designed to support controlled skin treatment procedures while helping practices maintain treatment consistency and workflow efficiency. Precision device settings and ergonomic functionality assist practitioners in delivering more customized treatment experiences. By focusing on professional usability and treatment reliability, Dp Derm supports aesthetic practices seeking advanced skin rejuvenation technologies that fit modern procedural standards.

Q5

What role does innovation play in Dp Derm’s product development?

Innovation remains central to Dp Derm’s approach within the Microneedling Devices market. The company integrates device refinement, treatment-focused engineering and evolving aesthetic technology advancements into its product development strategy. Continued attention to precision control, usability improvements and treatment adaptability helps support changing practitioner expectations and procedural trends. This commitment to advancement allows Dp Derm to maintain relevance within a competitive aesthetics technology landscape while supporting modern skin treatment methodologies.

Q6

Why is Dp Derm relevant to current aesthetic treatment needs?

Demand for minimally invasive aesthetic procedures continues to increase across skincare and cosmetic treatment environments. Dp Derm remains relevant because its Microneedling Devices are designed to support precision-driven skin rejuvenation procedures with professional-grade consistency and usability. The company’s focus on treatment control, device reliability and practitioner support aligns with the evolving priorities of aesthetic clinics and skincare professionals. Its specialized approach to microneedling technology continues to support growing interest in advanced non-surgical skin treatment solutions.

Microneedling Device Company of the Year 2026

Company
Dp Derm

Management
Joel Marshall, CEO

Description
Dp Derm provides microneedling devices, protocol-based skincare, practitioner education and homecare support for aesthetic clinics and med spas. Its model helps providers deliver more structured skin and hair treatments, improve client outcomes and build stronger continuity from preparation through recovery.